fashion -WSS

fashion

author：hotspot 2025-09-03 09:18:35 - browse：1826

Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： First Opinion Podcast: How to protect health care in times of war

Wikipedia

focus

WSS

Eli Lilly to pay $200M for Beam’s stake in gene

Readout Newsletter: XBI biotech index, Akero Therapeutics

Physician subsidies by hospitals soar in wake of No Surprises Act

Eli Lilly to pay $200M for Beam’s stake in gene

Hospitals look to new technology to keep health care workers safe

Surge of respiratory disease in China has likely explanation

leisure time

fashion

focus

Medical leaders decry Supreme Court decision on affirmative action

In key trial, Verve's treatment lowers cholesterol levels in patients

Alkermes shareholders re

The FDA weighs the risks of candy

Cancer drug shortages should be causing more outrage

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Heart attack and stroke risk calculators need revising

Chimpanzees, like humans and whales, get menopause: Study

Virginia high school admissions case could be legal follow

Weight loss drug costs may need more research, senator suggests

entertainment

Hospitals warn Medicare's drug payment fix is ‘unlawful’

CDC recommends rationing of RSV shot due to shortages

CRISPR pioneers react to Casgevy, first gene

Wegovy, Zepbound and weight loss drugs that preserve muscle

Senate panel to vote on hospitals, PBMs, prisoner care

Does good food count as health care? Study aims to find out

Wikipedia

focus

hotspot

knowledge